ARCHIVES

Research Dollars Save Money, Lives, Scientists Tell Senate

This article is from The Cancer Letter archive.

Vol. 17 No. 18 | May 3, 1991

Download PDF Visit The Full Archive

Related Articles

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported

November 17, 1978

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

House subcommittee proposes 2.8 percent increase for NIH, NCI.

July 16, 2004